Spinal taps uncover Alzheimer's, study says

Share this article:

Scientists might one day be able to identify people in the early stages of Alzheimer's through their cerebrospinal fluid.



Abnormal levels of molecules in the fluid — b-amyloid, total tau and phosphorylated-tau — predicted development of Alzheimer's with accuracy, according to a recent study by Swedish neurologists. The findings were published in Monday's online edition of Lancet Neurology.

The study followed 180 people over four to five years. Combined molecule measurements at the start of the study identified those who developed Alzheimer's with better than 90% accuracy.

While the Swedish study offers key information, spinal taps to collect cerebrospinal fluid are not easily done in routine medical practice, according to Dr. John Morris, a professor of neurology at Washington University School of Medicine in St. Louis. Other possible downsides to the test are the cost of the spinal tap and patient resistance to the invasive procedure.
Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.